Cargando…
PMON149 Identification of TR4 Modulators for Treatment of Cushing Disease.
Cushing Disease (CD) is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor that causes excess adrenal-derived cortisol. It is a life-threatening "orphan disease" with an annual health care cost >7-fold higher than average patients. Surgical removal is the current...
Autores principales: | Zhang, Dongyun, Damoiseaux, Robert, Babayan, Lilit, Heany, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625701/ http://dx.doi.org/10.1210/jendso/bvac150.1126 |
Ejemplares similares
-
PMON73 Lipid profile in patients with Cushing's syndrome and the impact of surgical treatment
por: Varghese, Ron, et al.
Publicado: (2022) -
PMON102 Utility of the Desmopressin Stimulation Test to Detect Cyclic Cushing's Disease
por: Elenius, Henrik, et al.
Publicado: (2022) -
PMON87 A Case of Mineralocorticoid Induced Hypertension Secondary to Cushing's Syndrome
por: Abideen, Zain U, et al.
Publicado: (2022) -
MON-461 Drug Repurposing to Explore Novel Treatment for Cushing Disease
por: Zhang, Dongyun, et al.
Publicado: (2019) -
PMON94 Collision tumor with Rathke cleft cyst and co existing Cushing's disease
por: Mittal, Ashima, et al.
Publicado: (2022)